V
Market Data
$5.39+$0.95 (+21.40%)
VNDA · Last trade
Prev Close
$4.44
Range (29d)
$4.34 – $5.39
Recent Filings
- 8-K232.2 KBVanda Pharmaceuticals Inc.Dec 4, 4:39 PM ET·0001628280-25-055393
- 8-K233.0 KBVanda Pharmaceuticals Inc.Nov 28, 7:06 AM ET·0001628280-25-054225
- 449.9 KBVanda Pharmaceuticals Inc.Dec 18, 7:43 PM ET·0001193805-15-002110
- 4/A53.7 KBVanda Pharmaceuticals Inc.Dec 18, 7:40 PM ET·0001193805-15-002109
- 8-K28.8 KBVanda Pharmaceuticals Inc.May 30, 5:01 PM ET·0001193125-12-253648
- 8-K17.8 KBVanda Pharmaceuticals Inc.Jul 1, 7:59 AM ET·0000950123-10-062976
- 8-K101.1 KBVanda Pharmaceuticals Inc.May 4, 8:11 AM ET·0000950123-10-043173
- 8-K12.3 KBVanda Pharmaceuticals Inc.Dec 1, 1:03 PM ET·0000950123-09-067174
- 8-K87.8 KBVanda Pharmaceuticals Inc.Nov 2, 4:04 PM ET·0000950123-09-056228
- SC 13G/A7.9 KBVanda Pharmaceuticals Inc.Aug 11, 4:15 PM ET·0000315066-08-003207
Insiders
10- BLAIR JAMES C10% Owner
- CARE CAPITAL II LLC10% Owner
- CARE CAPITAL INVESTMENTS II LP10% Owner
- Clark William DSr. VP, Chief Business Officer
- DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Member of 10% Group
- Deerfield Mgmt L.P.10% Owner, Possible Member of 10% Group
- DOVEY BRIAN H10% Owner
- Feeney John JosephActing Chief Medical Officer
- Flynn James E10% Owner, Possible Member of 10% Group
- Irish Stephanie RastActing CFO/Treasurer
Tickers
Addresses
business
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037
mailing
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037